SuPrep
Total Payments
$210,542
Transactions
63
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2018 | $210,542 | 63 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $210,542 | 63 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| BLI800-502 | Braintree Laboratories, Inc. | $210,542 | 0 |
Top Doctors Receiving Payments for SuPrep
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Buffalo, NY | $210,542 | 63 |
Ad
Manufacturing Companies
- Braintree Laboratories, Inc. $210,542
Product Information
- Type Drug
- Total Payments $210,542
- Total Doctors 0
- Transactions 63
About SuPrep
SuPrep is a drug associated with $210,542 in payments to 0 healthcare providers, recorded across 63 transactions in the CMS Open Payments database. The primary manufacturer is Braintree Laboratories, Inc..
Payment data is available from 2018 to 2018. In 2018, $210,542 was paid across 63 transactions to 0 doctors.
The most common payment nature for SuPrep is "Unspecified" ($210,542, 100.0% of total).
SuPrep is associated with 1 research study, including "BLI800-502" ($210,542).